Budapest, Monor Campus
Budapest, Monor Campus

Budapest – Ceva’s Hungarian Headquarters​

Since the founding of Phylaxia in 1912, our presence in Hungary dates back more than a century. We remain proud of our heritage, which serves as the foundation for our continuous development.

We currently employ more than 1,400 people, and our team is steadily expanding. ​

Our Budapest site is a cornerstone of the Ceva Group, both locally and globally. In addition to producing 50 different vaccines to prevent 25 diseases, it hosts the group's largest biological R&D center and our SSIU Directorate.

​

Monor – The Future of Our Expansion​

Since 2021, we have been operating across two locations. Our 50-hectare greenfield Linilog logistics center in Monor is unique in Europe: alongside storage and logistics operations, active manufacturing is also currently taking place here. In addition, it houses the continent’s largest cryogenic vaccine storage system, where products are stored at –196°C in liquid nitrogen. 

The Monor site will accommodate additional operations in the future. A new manufacturing facility is currently under development and will, according to plans, begin operations in 2027, creating 120 new high-skilled jobs.​

079_elszov_ceva_web_gergelykaszas.jpg
Ceva Wildlife Research Fund
White logo Ceva

Ceva Wildlife Research Fund, empowering science to protect vulnerable animals.